BioNTech’s Covid-19 vaccine boosts revenue to £8bn so far this year
Published
BioNtech, the company which worked with Pfizer to develop its famed Covid-19 vaccine, has reported €9.6bn (£8bn) worth of revenue so far this year. The Germany pharmaceutical giant snagged €3.2bn (£2.6bn) in revenue in the second quarter of this year, the company reported today. In a call today, CEO Uğur Şahin said the results [...]
Full Article